Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 9:51 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 499 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Botulinum Toxins, Type A Clear all

Conditions: Glabellar Frown Lines
Interventions: QM1114-DP, Placebo; Biological
Lead sponsor: Galderma R&D; Industry
Eligibility: 18 Years and older
Enrollment: 132 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 9
States / cities: Homewood, Alabama • Manhattan Beach, California • Vista, California + 6 more

Conditions: Lateral Canthal Lines
Interventions: botulinum toxin, Placebo; Biological
Lead sponsor: Galderma R&D; Industry
Eligibility: 18 Years and older
Enrollment: 303 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 8
States / cities: Manhattan Beach, California • San Diego, California • Solana Beach, California + 5 more

Conditions: New Daily Persistent Headache
Interventions: OnabotulinumtoxinA; Drug
Lead sponsor: St. Luke's-Roosevelt Hospital Center; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Lower Limb Spasticity
Interventions: Botulinum toxin type A; Biological
Lead sponsor: Ipsen; Industry
Eligibility: 2 Years to 17 Years
Enrollment: 242 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 27
States / cities: Washington D.C., District of Columbia • Miami, Florida • North Palm Beach, Florida + 23 more

Conditions: Oral Dystonia, Tardive Dystonia
Interventions: Low Dose - AbobotulinumtoxinA; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Diabetes Mellitus, Peripheral Neuropathy, Plantar Ulcers
Interventions: Botulinum Toxin, Saline; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: Not listed
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Stroke With Hemiparesis
Interventions: Botulinum Toxin commonly known as BOTOX®, Placebo; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Glabellar Lines, Lateral Canthal Lines
Interventions: botulinum toxin neuromodulator; Biological
Lead sponsor: Galderma R&D; Industry
Eligibility: 18 Years and older
Enrollment: 902 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 29
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Fremont, California + 22 more

Conditions: Pain From onabotulinumtoxinA Injections
Interventions: onabotulinumtoxinA prophylaxis with Lidocaine, OnabotulinumtoxinA prophylaxis with Saline; Procedure
Lead sponsor: Association of Migraine Disorders; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: East Providence, Rhode Island

Conditions: Urinary Incontinence
Interventions: Bladder diary, Questionnaires, Urodynamics, Pad weight; Other · Procedure
Lead sponsor: University of Rochester; Other
Eligibility: 21 Years and older · Female only
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Glabellar Lines
Interventions: Formulation A: OnabotulinumtoxinA, Formulation B: OnabotulinumtoxinA, Formulation C: OnabotulinumtoxinA; Drug
Lead sponsor: Allergan; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 5
States / cities: Glendale, Arizona • Coral Gables, Florida • New Orleans, Louisiana + 2 more

Conditions: Migraine Headaches
Interventions: Botulinum Toxin Type A, Surgery, Daily headache diary, Migraine Disability Assessment Test (MIDAS), Migraine Work and Productivity Loss Questionnaire (MWPLQ), Migraine-Specific Quality of Life Questionnaire (MSQ); Drug · Procedure · Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 6
States / cities: San Francisco, California • Olathe, Kansas • Boston, Massachusetts + 3 more

Conditions: Cervical Dystonia
Interventions: Not listed
Lead sponsor: Ipsen; Industry
Eligibility: 18 Years and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 45
States / cities: Scottsdale, Arizona • Berkeley, California • Encinitas, California + 39 more

Conditions: Pain
Interventions: Music; Other
Lead sponsor: Rowan University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Stratford, New Jersey

Conditions: Chronic Migraine
Interventions: onabotulinumtoxinA, Topiramate, Placebo; Drug
Lead sponsor: Cady, Roger, M.D.; Individual
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Springfield, Missouri

Conditions: Carpal Tunnel Syndrome
Interventions: Botulinum toxin, Corticosteroid injection into Carpal Tunnel; Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Post-Operative Atrial Fibrillation
Interventions: AGN-151607, Placebo; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 55 Years to 90 Years
Enrollment: 323 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 19
States / cities: Stanford, California • New Haven, Connecticut • Washington D.C., District of Columbia + 16 more

Conditions: Depressive Disorder, Major
Interventions: onabotulinumtoxinA, Normal Saline; Biological · Drug
Lead sponsor: Allergan; Industry
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 258 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 35
States / cities: Little Rock, Alaska • Bellflower, California • Cerritos, California + 29 more

Conditions: Endometriosis, Chronic Pelvic Pain, Pelvic Muscle Spasm, Quality of Life
Interventions: Botulinum toxin (BoNT), Placebo; Drug
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Dermatological Non-Disease
Interventions: Botox Cosmetic Injectable Product, Juvéderm Voluma XC, Juvéderm Volbella XC; Drug · Device
Lead sponsor: State University of New York - Downstate Medical Center; Other
Eligibility: 24 Years to 40 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Cervical Dystonia
Interventions: No Intervention; Other
Lead sponsor: Allergan; Industry
Eligibility: Not listed
Enrollment: 1,046 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Springfield, Massachusetts

Conditions: Urinary Incontinence
Interventions: Botox, Placebo; Drug
Lead sponsor: University of Rochester; Other
Eligibility: 21 Years to 90 Years · Female only
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2011
U.S. locations: 3
States / cities: Sacramento, California • Boston, Massachusetts • Durham, North Carolina

Conditions: Chronic Migraine, Headache
Interventions: Daxibotulinumtonix A; Biological
Lead sponsor: Ki Health Partners. LLC; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 20 participants
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Los Angeles, California • Stamford, Connecticut

Conditions: Hyperhidrosis
Interventions: Botulinum Toxin Type A; Biological
Lead sponsor: Allergan; Industry
Eligibility: 18 Years and older
Enrollment: 424 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 1
States / cities: Portland, Oregon

Search by objective public record fields.

Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines

Treatment of Moderate to Severe Lateral Canthal Lines

OnabotulinumtoxinA for the Treatment of New Daily Persistent Headache: an Open Label Study

Effectiveness and Safety of Dysport® (abobotulinumtoxinA) in Paediatric Lower Limb Spasticity

Dysport for the Treatment of OMD

Botulinum Toxin Effects on Plantar Ulcer Recurrence

Study of Botulinum Toxin and Recovery of Hand Function After Stroke

Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines

Topical Intranasal Anesthetic Block for Reducing the Pain of Botulinum Toxin Injections for Chronic Migraine

Randomized Trial for Botox Urinary Incontinence

A Study of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines

Prospective, Multi-Center Evaluation of the Efficacy of Peripheral Trigger Decompression Surgery for Migraine Headaches

DYSPORT™ Clinical & Health Economics Outcomes Registry in Cervical Dystonia

The Effect of Music Meditation Therapy in Patients With Chronic Pain Receiving Botox

A Study to Evaluate the Tolerability of Botox and Topiramate or Botox and Placebo and Effect on Cognitive Efficiency

Botulinum Toxin for Carpal Tunnel Syndrome

Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Adult Participants Undergoing Open-chest Cardiac Surgery (NOVA)

OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females

Botulinum Toxin for Pelvic Pain in Women With Endometriosis

Combination Facial Aesthetic Treatment in Millennials

CD-PROBE: Cervical Dystonia Patient Registry for the Observation of onabotulinumtoxinA Efficacy

A Multi-Center Trial of Botox for Severe Urge Urinary Incontinence

Open Label, 6-month Study for High Frequency and Chronic Migraine,

A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis